
Trump tariffs would hit Hungary hard despite warm relations with MAGA-friendly Orbán
But despite Viktor Orbán's success in gaining favor with the culturally conservative and nationalist wing of Trump's administration, his country is poised to be among those hard hit by Trump's tariffs against the European Union.
Trump earlier this month announced he would levy tariffs of 30% against Mexico and the EU beginning Aug. 1 — a move that could cause massive upheaval between the United States and the 27-member EU, of which Hungary is a member.
As a small, export-oriented economy with major automobile, pharmaceutical and wine industries — some of the main categories of products Europe exports to the U.S. — Hungary will be particularly vulnerable to Trump's tariffs.
The duties 'would put the Hungarian economy in a very, very difficult situation, because then the entire possibility for Hungary to export to America would be essentially eliminated,' Péter Virovácz, chief analyst at ING Hungary, told The Associated Press.
'Not the best way to make money'
Hungary's largest trading partners are other EU countries like Germany, Italy and Romania, as well as China, but many Hungarian companies export their goods across the Atlantic. Outgoing trade to the United States represents around 15% of all Hungarian exports to countries outside the EU.
One such enterprise, a Budapest-based company specializing in Hungarian wine, said it will likely cease doing business in the U.S. altogether if the 30% duty is levied on its products.
'If it's really going to be 30%, then there is no more shipment … We might just call it a day at the end of the year,' said Gábor Bánfalvi, co-owner of Taste Hungary.
Bánfalvi's company has been shipping around 10,000 bottles of premium Hungarian wine per year to the U.S. for about half a decade. With a base in Washington D.C., it exports a range of red and white wines to clients in numerous U.S. states including specialty wine shops and bars.
Until now, 'it's been a thin profit margin, but it's been fine because we want Hungarian wine to be available' to U.S. consumers, Bánfalvi said.
'Then came 2025,' he said.
When Trump began imposing tariffs on EU exports earlier this year, the cost of Taste Hungary's shipments tripled, Bánfalvi said — price hikes he had to build into the sticker price of the wine. The imposition of 30% tariffs would make exporting 'unsustainable.'
'You just start to think, why are we doing this? Is it really worth it? It's just not the best way to make money,' he said.
In total, the value of EU-U.S. trade in goods and services in 2024 amounted to 1.7 trillion euros ($2 trillion.)
Doubts that political ties could soften the blow
Hungary's government, a vocal proponent of Trump's 'patriotic' foreign policy prioritizing national interests, has acknowledged that the tariffs would present a challenge. But, careful not to criticize the Trump administration, it has instead blamed the EU, a frequent target of Orbán's scorn, for failing to reach a comprehensive trade agreement with Washington.
Confident that his right-wing populist policies would help win him favor with Trump's administration, Orbán said in an interview in April that while tariffs 'will be a disadvantage,' his government was negotiating 'other economic agreements and issues that will offset them.'
But Péter Krekó, director of the Budapest-based Political Capital think tank, expressed doubt that political affinities could play a meaningful role in mitigating damage to Hungary's economy caused by Trump's trade policy.
'The unquestionably good bilateral relations simply cannot compensate for the trade conflicts between the EU and the U.S., and as a consequence, Hungary will suffer the tariffs the same way that the EU will,' Krekó said. 'Mutual nationalisms cannot be coordinated in a way that it is going to be a win-win situation.'
Car manufacturing and pharmaceuticals
Virovácz, the economist, pointed out that Hungary is home to numerous automobile factories for major automakers like Audi and Mercedes. The manufacturing of cars and motor vehicle parts represents an 'overwhelming majority' of the country's total exports, he said.
Pharmaceuticals make up an even larger share of Hungarian exports to the United States — an industry on which Trump this month threatened to impose 200% tariffs. That 'will essentially kill European and thus Hungarian exports to America,' Virovácz said.
'It's impossible for tariffs to be levied on EU products but not on Hungarian ones,' he said. 'A theoretical option is that Trump could somehow compensate Hungary because he's on good terms with the Hungarian political leadership, but if that only starts happening now, it's way too late.'
Krekó, the political analyst, said Trump's administration 'gives practically nothing for free. If Hungary … cannot fulfill the interests of the U.S., then I think Hungary is not going to receive gifts.'
'Hungary just doesn't have the cards, to use Trump's terminology,' he added.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Trump sends letters to pharma CEOs demanding they reduce drug prices in 60 days
President Trump escalated efforts to reduce drug prices in the US on Thursday, releasing letters sent to 17 pharmaceutical company CEOs on Truth Social. The letters, addressed to Eli Lilly (LLY), Pfizer (PFE), AstraZeneca (AZN), and others, include a 60-day deadline to implement Trump's most-favored nations clause — to reduce prices of drugs at the rates of the lowest that it sells to any developed nation — for Medicare and Medicaid enrollees. All three company stocks were trading down between 1% and 3.5% after the letters were posted. AstraZeneca declined to comment to Yahoo Finance, and requests for comment from other pharma companies were not immediately returned. "I am calling on [company] and every manufacturer doing business in our great country to take the following actions within the next 60 days," Trump wrote. "Domestic MFN pricing will require you, and all manufacturers, to negotiate harder with foreign freeloading nations," he added. Trump said that Health and Human Services (HHS) Sec. Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz will be involved in the process and "stand ready to implement these terms." He ended the letters with a deadline of September 29 this year. The letters add to pressure from the White House, even as many of these CEOs have had comfortable relationships with the president. Pfizer CEO Albert Bourla, who has known Trump since his first term due to the pandemic, is also the chair of the industry's largest lobbying group, PhRMA. In both roles, he has been able to communicate directly with Trump and indicated he has done so on tariffs and other topics. He isn't alone. Eli Lilly CEO David Ricks has also been seen in Washington, D.C., and has said he has spoken to the administration. AstraZeneca CEO Pascal Soriot has taken steps to turn the UK-based company's image into a more American one, with rumors of making the company's main listing in New York rather than London. In addition, Soriot said this week that he has sent his own proposal for reduced drug prices to the White House, with a response pending. In a statement Thursday, the White House acknowledged it had met with the companies but that "industry proposals have fallen short." The CEOs have been largely focused on cultivating a relationship with the White House and the Trump administration in hopes of avoiding tariffs on drug imports. They have collectively committed to more than $200 billion in manufacturing investments through the end of the decade and have expressed interest in helping to produce lower-cost drugs onshore, rather than lower-cost production overseas. A majority of branded drug prices in the US are higher, while generics cost less and make up a majority of the drugs consumed by Americans. "It is estimated that 91% of all prescriptions in the United States are filled as generic drugs, with more than 32,000 generic drugs approved by the FDA to date," a 2022 report from the FDA said. In a press briefing from the White House, spokesperson Karoline Leavitt read the letter to Eli Lilly aloud. She added, "According to recent data, the prices that Americans have been paying for branded drugs are more than three times the price other similarly developed nations pay. The president is determined to solve this problem." Trump has tried since his first term to pass a most-favored-nations clause for drug pricing, which would force companies to match pricing in other countries. He signed an executive order on May 12 to provide pathways for the administration to implement the clause. In a statement from the White House Thursday, Trump said, "In case after case, our citizens pay massively higher prices than other nations pay for the same exact pill, from the same factory, effectively subsidizing socialism [abroad] with skyrocketing prices at home." Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Click here for in-depth analysis of the latest health industry news and events impacting stock prices Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


The Hill
12 minutes ago
- The Hill
Biden, Harris step back into the spotlight
U.S. officials met with Israeli Prime Minister Benjamin Netanyahu on Thursday about delivering aid to Gaza, as public pressure grows on Israel to address the humanitarian and hunger crisis. President Trump 's envoy to the Middle East, Steve Witkoff, and U.S. ambassador to Israel Mike Huckabee had a 'very productive' meeting with Netanyahu in Israel, according to White House press secretary Karoline Leavitt. Witkoff and Huckabee will travel into Gaza on Friday to 'inspect the current distribution sites' and to 'come up with a plan to deliver more food,' Leavitt said. They'll also 'meet with local Gazans to hear first hand about this dire situation on the ground.' Witkoff and Huckabee will brief Trump after the visit to approve a food distribution plan. Peace talks have stalled and Israel is facing a growing public pressure campaign to ensure food and aid is getting into Gaza. Trump said this week the U.S. would work to set up 'food centers' in Gaza to address the 'real starvation' that is taking place. Netanyahu says there is no hunger crisis, but both he and Trump have blamed Hamas for disrupting aid distribution in the region. Netanyahu is nearing a political inflection point as some Republicans from the MAGA wing of the party speak out against U.S. support for Israel. 'Are innocent Israeli lives more valuable than innocent Palestinian and Christian lives? And why should America continue funding this?' Rep. Marjorie Taylor Greene (R-Ga.) posted on X. 'The secular government of nuclear armed Israel has proven that they are beyond capable of dealing with their enemies and are capable of and are in the process of systematically cleansing them from the land.' On Wednesday, a record number of Senate Democrats — more than half the caucus — voted in favor of two resolutions to block U.S. military sales to Israel. The resolutions ultimately failed but it was another warning shot at Netanyahu that his once-firm support in the U.S. is crumbling. Sen. Jon Ossoff (Ga.), who is among the most vulnerable Democrats up for reelection in 2026, voted in favor of the resolutions. 'I do not believe the United States Senate should acquiesce without objection to the extreme mass deprivation of civilians in Gaza, including the intolerable starvation of children, that have resulted from the policies of Prime Minister Benjamin Netanyahu's government,' Ossoff said. 'Despite my opposition to Prime Minister Netanyahu's conduct of the war in Gaza, I believe the United States must continue to support the Israeli people…Hamas, a despicable terrorist organization, started this horrific round of conflict with the brutal massacre of October 7th, 2023. Their abhorrent tactics, their refusal to release hostages, and their refusal to lay down their arms continue to deepen and prolong civilian suffering in Gaza.' • Trump is ramping up his attacks against GOP senators, who he believes aren't doing enough to stand up for him. Sen. Josh Hawley (R-Mo.) said he had a 'good chat' with Trump after the president unloaded on him for supporting a bill that would prohibit lawmakers, future presidents and vice presidents from trading stocks. Hawley, who sponsored the bill, was the only Republican to join all Democrats in passing it out of committee. The Hill's Sarah Fortinsky writes: 'Hawley's bill was originally called the Preventing Elected Leaders from Owning Securities and Investments (PELOSI) Act — a nod to the criticism former Speaker Nancy Pelosi (D-Calif.) has faced amid scrutiny over her husband's stock trading. The Missouri Republican changed the name in exchange for Democrats' support.' Pelosi signaled her support for the legislation, while pushing back on claims she's ever traded on insider information. 'If legislation is advanced to help restore trust in government and ensure that those in power are held to the highest ethical standards, then I am proud to support it — no matter what they decide to name it,' she said in a statement. The dust-up between Trump and Hawley comes a day after Trump targeted Senate Judiciary Committee Chairman Chuck Grassley (R-Iowa) for honoring a longstanding agreement with Democrats over an obscure procedural rule. Trump's attacks on Grassley, 91, irked GOP senators. The Hill's Alexander Bolton reports: 'Republican senators were appalled by President Trump's rough treatment of 91-year-old Sen. Chuck Grassley (Iowa), the Senate's most senior Republican, on social media and are pushing back on Trump's attempts to squeeze the senator into abolishing an arcane procedure known as the Senate blue slip.'


Business Journals
12 minutes ago
- Business Journals
St. Louis drone maker WingXpand secures major government contracts for its backpack-sized aircraft
WingXpand's innovative approach to drone design is attracting attention in Washington, with several branches of the U.S. military now placing orders for the St. Louis-based company's compact aircraft.